A detailed history of New England Capital Financial Advisors LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, New England Capital Financial Advisors LLC holds 528 shares of EW stock, worth $40,085. This represents 0.02% of its overall portfolio holdings.

Number of Shares
528
Previous 528 -0.0%
Holding current value
$40,085
Previous $48.8 Million 28.56%
% of portfolio
0.02%
Previous 0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 03, 2023

BUY
$68.3 - $87.44 $36,062 - $46,168
528 New
528 $41.9 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track New England Capital Financial Advisors LLC Portfolio

Follow New England Capital Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Capital Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on New England Capital Financial Advisors LLC with notifications on news.